Outlook Therapeutics Inc., of Cranbury, N.J., approved a 1-for-8 reverse stock split, effective March 18. The number of shares of common stock issued and outstanding will be reduced from approximately 94.1 million to approximately 11.8 million. The number of authorized shares won't change.